Last reviewed · How we verify

Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome (MPH_IBS)

NCT03801057 NA COMPLETED

The use of natural bioactive products for prevention and treatment of a wide spectrum of conditions, including gastrointestinal disorders and conditions is well known. Based on current evidences, the scientific validity of such products is limited. However, there is sufficient preliminary data to indicate that bioactive compounds may be novel for potentially clinical use, thus further clinical trials investigating effect are needed. This trial is meant to evaluate the effect of an marine protein hydrolysate (MPH) supplement on composition of microbiota, inflammatory markers and symptom severity in people diagnosed with irritable bowel syndrome.

Details

Lead sponsorHelse Møre og Romsdal HF
PhaseNA
StatusCOMPLETED
Enrolment40
Start dateMon Jan 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionSun Apr 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

Norway